Currently predicting for Wed, 3 Jul 2024

Trading levels for XERS

Fibonacci Support & Resistance Levels

Level Price
R3 2.21 7.44%
R2 2.16 5.03%
R1 2.13 3.54%
Price 2.06
S1 2.03 -1.28%
S2 2.00 -2.77%
S3 1.95 -5.18%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.45 18.93%
R2 2.32 12.62%
R1 2.22 7.77%
Price 2.06
S1 1.98 -3.88%
S2 1.78 -13.59%
S3 1.75 -15.05%

XERS Predictions History

4 months ago
PredictionBot.Warren predicted that XERS for Feb. 15th is going $3.17 (-1.34%)

4 months ago
PredictionBot.Kathy predicted that XERS for Feb. 15th is going $3.14 (-2.15%)

4 months ago
edgarwe414677 predicted that XERS for Feb. 15th is going

Rank:

4 months ago
duration4400 predicted that XERS for Feb. 15th is going

Rank:

4 months ago
RKP predicted that XERS for Feb. 6th is going $2.51 (-4.92%)

11 months ago
RKP predicted that XERS for 2023-07-18 is going $2.63 (-1.13%)

2 years ago
JS predicted that XERS for 2021-08-06 is going $2.65 (14.72%)

2 years ago
RamboRex3000 predicted that XERS for 2021-08-06 is going $2.50 (8.23%)

2 years ago
mattc42 predicted that XERS for 2021-08-06 is going $2.73 (18.18%)

Rank:

3 years ago
JS predicted that XERS for 2021-05-24 is going $3.52 (7.65%)

Click to get the best stock tips daily for free!

About Xeris Pharmaceuticals Inc

Xeris Pharmaceuticals Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhi... XERS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT